Silver Book Fact

A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.

PhRMA Japan. Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer; 10-Sep-2000

Reference

Title
Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer
Publication Date
10-Sep-2000
Authors
PhRMA Japan

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Americans Age 65 and Older with Alzheimer’s Disease, 2010–2050  
  • Slowing the progression of Parkinson’s disease by just 10% would save $327 million (in direct and indirect costs) to the U.S. annually.  
  • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
     
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…